Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Mol Cell ; 71(6): 1064-1078.e5, 2018 09 20.
Artigo em Inglês | MEDLINE | ID: mdl-30197300

RESUMO

ß-hydroxybutyrate (ß-HB) elevation during fasting or caloric restriction is believed to induce anti-aging effects and alleviate aging-related neurodegeneration. However, whether ß-HB alters the senescence pathway in vascular cells remains unknown. Here we report that ß-HB promotes vascular cell quiescence, which significantly inhibits both stress-induced premature senescence and replicative senescence through p53-independent mechanisms. Further, we identify heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) as a direct binding target of ß-HB. ß-HB binding to hnRNP A1 markedly enhances hnRNP A1 binding with Octamer-binding transcriptional factor (Oct) 4 mRNA, which stabilizes Oct4 mRNA and Oct4 expression. Oct4 increases Lamin B1, a key factor against DNA damage-induced senescence. Finally, fasting and intraperitoneal injection of ß-HB upregulate Oct4 and Lamin B1 in both vascular smooth muscle and endothelial cells in mice in vivo. We conclude that ß-HB exerts anti-aging effects in vascular cells by upregulating an hnRNP A1-induced Oct4-mediated Lamin B1 pathway.


Assuntos
Ácido 3-Hidroxibutírico/farmacologia , Senescência Celular/efeitos dos fármacos , Animais , Células Cultivadas , Regulação da Expressão Gênica , Ribonucleoproteína Nuclear Heterogênea A1/efeitos dos fármacos , Ribonucleoproteína Nuclear Heterogênea A1/metabolismo , Ribonucleoproteínas Nucleares Heterogêneas Grupo A-B/metabolismo , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Fator 3 de Transcrição de Octâmero/efeitos dos fármacos , Fator 3 de Transcrição de Octâmero/metabolismo , RNA Mensageiro , Ativação Transcricional , Regulação para Cima
2.
FASEB J ; 32(6): 3108-3118, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29401599

RESUMO

Although thioredoxin-interacting protein (TXNIP) is involved in a variety of biologic functions, the contribution of endothelial TXNIP has not been well defined. To investigate the endothelial function of TXNIP, we generated a TXNIP knockout mouse on the Cdh5-cre background (TXNIPfl/fl cdh5cre). Control (TXNIPfl/fl) and TXNIPfl/fl cdh5cre mice were fed a high protein-low carbohydrate (HP-LC) diet for 3 mo to induce metabolic stress. We found that TXNIPfl/fl and TXNIPfl/fl cdh5cre mice on an HP-LC diet displayed impaired glucose tolerance and dyslipidemia concretizing the metabolic stress induced. We evaluated the impact of this metabolic stress on mice with reduced endothelial TXNIP expression with regard to arterial structure and function. TXNIPfl/fl cdh5cre mice on an HP-LC diet exhibited less endothelial dysfunction than littermate mice on an HP-LC diet. These mice were protected from decreased aortic medial cell content, impaired aortic distensibility, and increased plasminogen activator inhibitor 1 secretion. This protective effect came with lower oxidative stress and lower inflammation, with a reduced NLRP3 inflammasome expression, leading to a decrease in cleaved IL-1ß. We also show the major role of TXNIP in inflammation with a knockdown model, using a TXNIP-specific, small interfering RNA included in a lipoplex. These findings demonstrate a key role for endothelial TXNIP in arterial impairments induced by metabolic stress, making endothelial TXNIP a potential therapeutic target.-Bedarida, T., Domingues, A., Baron, S., Ferreira, C., Vibert, F., Cottart, C.-H., Paul, J.-L., Escriou, V., Bigey, P., Gaussem, P., Leguillier, T., Nivet-Antoine, V. Reduced endothelial thioredoxin-interacting protein protects arteries from damage induced by metabolic stress in vivo.


Assuntos
Aorta/metabolismo , Proteínas de Transporte/metabolismo , Dislipidemias/metabolismo , Intolerância à Glucose/metabolismo , Estresse Fisiológico , Tiorredoxinas/metabolismo , Animais , Aorta/patologia , Proteínas de Transporte/genética , Dieta com Restrição de Carboidratos/efeitos adversos , Proteínas Alimentares/efeitos adversos , Proteínas Alimentares/farmacologia , Dislipidemias/induzido quimicamente , Dislipidemias/genética , Dislipidemias/patologia , Intolerância à Glucose/induzido quimicamente , Intolerância à Glucose/genética , Intolerância à Glucose/patologia , Inflamassomos/genética , Inflamassomos/metabolismo , Camundongos , Camundongos Knockout , Proteína 3 que Contém Domínio de Pirina da Família NLR/biossíntese , Serpina E2/biossíntese , Tiorredoxinas/genética
3.
Am J Physiol Heart Circ Physiol ; 307(5): H649-57, 2014 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-25015969

RESUMO

High-protein-low-carbohydrate (HP-LC) diets have become widespread. Yet their deleterious consequences, especially on glucose metabolism and arteries, have already been underlined. Our previous study (2) has already shown glucose intolerance with major arterial dysfunction in very old mice subjected to an HP-LC diet. The hypothesis of this work was that this diet had an age-dependent deleterious metabolic and cardiovascular outcome. Two groups of mice, young and adult (3 and 6 mo old), were subjected for 12 wk to a standard or to an HP-LC diet. Glucose and lipid metabolism was studied. The cardiovascular system was explored from the functional stage with Doppler-echography to the molecular stage (arterial reactivity, mRNA, immunohistochemistry). Young mice did not exhibit any significant metabolic modification, whereas adult mice presented marked glucose intolerance associated with an increase in resistin and triglyceride levels. These metabolic disturbances were responsible for cardiovascular damages only in adult mice, with decreased aortic distensibility and left ventricle dysfunction. These seemed to be the consequence of arterial dysfunctions. Mesenteric arteries were the worst affected with a major oxidative stress, whereas aorta function seemed to be maintained with an appreciable role of cyclooxygenase-2 to preserve endothelial function. This study highlights for the first time the age-dependent deleterious effects of an HP-LC diet on metabolism, with glucose intolerance and lipid disorders and vascular (especially microvessels) and cardiac functions. This work shows that HP-LC lead to equivalent cardiovascular alterations, as observed in very old age, and underlines the danger of such diet.


Assuntos
Aorta/metabolismo , Dieta com Restrição de Carboidratos/efeitos adversos , Proteínas Alimentares/administração & dosagem , Intolerância à Glucose/etiologia , Miocárdio/metabolismo , Disfunção Ventricular Esquerda/etiologia , Fatores Etários , Animais , Aorta/patologia , Glicemia/metabolismo , Proteínas Alimentares/efeitos adversos , Ecocardiografia , Intolerância à Glucose/metabolismo , Metabolismo dos Lipídeos , Artérias Mesentéricas/metabolismo , Artérias Mesentéricas/patologia , Camundongos , Camundongos Endogâmicos C57BL , Miocárdio/patologia , Resistina/sangue , Triglicerídeos/sangue , Disfunção Ventricular Esquerda/metabolismo
4.
Nat Commun ; 10(1): 2145, 2019 05 13.
Artigo em Inglês | MEDLINE | ID: mdl-31086184

RESUMO

Although angiotensin II (AngII) is known to cause renal injury and fibrosis, the underlying mechanisms remain poorly characterized. Here we show that hypertensive nephropathy (HN) patients and AngII-infused mice exhibit elevated levels of circulating miR103a-3p. We observe a positive correlation between miR-103a-3p levels and AngII-induced renal dysfunction. miR-103a-3p suppresses expression of the sucrose non-fermentable-related serine/threonine-protein kinase SNRK in glomerular endothelial cells, and glomeruli of HN patients and AngII-infused mice show reduced endothelial expression of SNRK. We find that SNRK exerts anti-inflammatory effects by interacting with activated nuclear factor-κB (NF-κB)/p65. Overall, we demonstrate that AngII increases circulating miR-103a-3p levels, which reduces SNRK levels in glomerular endothelial cells, resulting in the over-activation of NF-κB/p65 and, consequently, renal inflammation and fibrosis. Together, our work identifies miR-103a-3p/SNRK/NF-κB/p65 as a regulatory axis of AngII-induced renal inflammation and fibrosis.


Assuntos
Angiotensina II/metabolismo , Glomerulonefrite/patologia , Hipertensão Renal/patologia , Glomérulos Renais/patologia , MicroRNAs/metabolismo , Nefrite/patologia , Proteínas Serina-Treonina Quinases/genética , Adulto , Angiotensina II/administração & dosagem , Animais , Estudos de Casos e Controles , Células Cultivadas , Modelos Animais de Doenças , Feminino , Fibrose , Glomerulonefrite/sangue , Glomerulonefrite/genética , Glomerulonefrite/urina , Voluntários Saudáveis , Humanos , Hipertensão Renal/sangue , Hipertensão Renal/genética , Hipertensão Renal/urina , Glomérulos Renais/citologia , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Knockout , MicroRNAs/sangue , MicroRNAs/urina , Pessoa de Meia-Idade , Nefrite/sangue , Nefrite/genética , Nefrite/urina , Cultura Primária de Células , Proteínas Serina-Treonina Quinases/metabolismo , Fator de Transcrição RelA/metabolismo
5.
Nat Commun ; 10(1): 3628, 2019 Aug 06.
Artigo em Inglês | MEDLINE | ID: mdl-31388007

RESUMO

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

6.
Diabetes ; 66(9): 2424-2435, 2017 09.
Artigo em Inglês | MEDLINE | ID: mdl-28659345

RESUMO

Neuropilin 1 (Nrp1), a coreceptor for class 3 semaphorins and growth factors, is highly expressed in vascular cells and myeloid cells, including macrophages. Unlike well-characterized proangiogenic functions of endothelial cell Nrp1, the contributions of macrophage Nrp1 within the context of metabolic dysfunction remain to be established. The aim of this study was to determine the contributions of macrophage Nrp1 in high-fat diet (HFD)-instigated insulin resistance in vivo. Insulin sensitivity and Nlrp3 inflammasome activation were monitored in wild-type (WT) and myeloid cell-specific Nrp1 knockout (Nrp1myel-KO) mice fed an HFD (60% kcal) for 16 weeks. HFD-fed mice exhibited insulin resistance with reduced levels of Nrp1 in macrophages compared with chow-fed mice. Further, HFD-fed Nrp1myel-KO mice displayed accentuated insulin resistance, enhanced systemic inflammation, and dramatically increased Nlrp3 inflammasome priming and activation. Importantly, knockout of Nlrp3 ablated HFD-induced insulin resistance and inflammation in Nrp1myel-KO mice, indicating that Nrp1 reduction in macrophages instigates insulin resistance by increasing macrophage Nlrp3 inflammasome activation. Mechanistically, Nrp1 deletion activates the nuclear factor-κB pathway, which in turn accentuates the priming of Nlrp3, promotes Nlrp3-ASC inflammasome assembly, and results in the activation of Nlrp3. We conclude that the HFD-instigated Nrp1 reduction in macrophages exacerbates insulin resistance by promoting Nlrp3 inflammasome priming and activation.


Assuntos
Dieta Hiperlipídica/efeitos adversos , Inflamassomos/metabolismo , Resistência à Insulina , Proteína 3 que Contém Domínio de Pirina da Família NLR/metabolismo , Neuropilina-1/metabolismo , Animais , Regulação da Expressão Gênica/fisiologia , Inflamassomos/genética , Macrófagos , Camundongos , Camundongos Knockout , Proteína 3 que Contém Domínio de Pirina da Família NLR/genética , Neuropilina-1/genética
7.
Mol Nutr Food Res ; 61(8)2017 08.
Artigo em Inglês | MEDLINE | ID: mdl-28160405

RESUMO

SCOPE: Trans-resveratrol is widely studied for its potentially beneficial effects on numerous disorders. It is rapidly metabolized and its metabolites can exhibit biological activity. The present study aimed to investigate whether acute or sustained trans-resveratrol administration impacted on the distribution of trans-resveratrol and its metabolites in brain, heart, and liver. METHODS AND RESULTS: We used ultra-HPLC quadrupole-TOF (UHPLC-Q-TOF) in a full-scan mode to identify and assess large numbers of resveratrol metabolites. For acute intake, mice were overfed with a single dose of trans-resveratrol (150 mg/kg) and organs were collected after 30 and 60 min. For sustained intake, trans-resveratrol was given in the chow (0.04% w/w corresponding to 40 mg/kg/day), and plasma and the organs were collected after 3 months of this resveratrol diet. We found that trans-resveratrol-3-O-glucuronide and resveratrol-3-sulfate were the main metabolites found after acute intake, and free trans-resveratrol (in the brain and heart) and dihydroresveratrol derivatives were found after sustained administration CONCLUSIONS: Our results show notable differences between acute and sustained administration of trans-resveratrol and distribution of trans-resveratrol and its metabolites in mouse heart, brain, and liver. The results suggest a strategy for development of galenic forms of resveratrol.


Assuntos
Glucuronídeos/farmacocinética , Estilbenos/farmacocinética , Animais , Encéfalo/efeitos dos fármacos , Encéfalo/metabolismo , Cromatografia Líquida de Alta Pressão/métodos , Coração/efeitos dos fármacos , Fígado/efeitos dos fármacos , Fígado/metabolismo , Espectrometria de Massas/métodos , Camundongos , Resveratrol , Estilbenos/metabolismo , Distribuição Tecidual
8.
J Gerontol A Biol Sci Med Sci ; 71(6): 720-9, 2016 06.
Artigo em Inglês | MEDLINE | ID: mdl-26041427

RESUMO

Aging leads to a high prevalence of glucose intolerance and cardiovascular diseases, with oxidative stress playing a potential role. Resveratrol has shown promising effects on glucose tolerance and tends to improve endothelial function in elderly patients. Thioredoxin-interacting protein (TXNIP) was recently proposed as a potential link connecting glucose metabolism to oxidative stress. Here, we investigated the resveratrol-induced improvement of arterial aging phenotype in old mice and the expression of aortic TXNIP. Using an in vivo model of old mice with or without 3-month resveratrol treatment, we investigated the effects of resveratrol on age-related impairments from a cardiovascular Doppler analysis, to a molecular level, by studying inflammation and oxidative stress factors. We found a dual effect of resveratrol, with a decrease of age-related glucose intolerance and oxidative stress imbalance leading to reduced matrix remodeling that forestalls arterial aging phenotype in terms of intima-media thickness and arterial distensibility. These results provide the first evidence that aortic TXNIP mRNA and protein nuclear expressions are increased in the arterial aging and decreased by resveratrol treatment. In conclusion, we demonstrated that resveratrol helped to restore several aging impaired processes in old mice, with a decrease of aortic TXNIP mRNA and protein nuclear expressions.


Assuntos
Aorta/diagnóstico por imagem , Aorta/metabolismo , Proteínas de Transporte/metabolismo , Intolerância à Glucose/tratamento farmacológico , Proteínas Nucleares/metabolismo , RNA Mensageiro/metabolismo , Estilbenos/farmacologia , Tiorredoxinas/metabolismo , Animais , Cálcio/sangue , Ecocardiografia Doppler , Teste de Tolerância a Glucose , Imuno-Histoquímica , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Estresse Oxidativo/efeitos dos fármacos , Fenótipo , Distribuição Aleatória , Reação em Cadeia da Polimerase em Tempo Real , Resveratrol
9.
J Gerontol A Biol Sci Med Sci ; 69(3): 260-9, 2014 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23793060

RESUMO

Aging leads to increased insulin resistance and arterial dysfunction, with oxidative stress playing an important role. This study explored the metabolic and arterial effects of a chronic treatment with resveratrol, an antioxidant polyphenol compound that has been shown to restore insulin sensitivity and decrease oxidative stress, in old mice with or without a high-protein diet renutrition care. High-protein diet tended to increase insulin resistance and atheromatous risk. Resveratrol improved insulin sensitivity in old mice fed standard diet by decreasing homeostasis model of assessment-insulin resistance and resistin levels. However, resveratrol did not improve insulin resistance status in old mice receiving the high-protein diet. In contrast, resveratrol exhibited deleterious effects by increasing inflammation state and superoxide production and diminishing aortic distensibility. In conclusion, we demonstrate that resveratrol has beneficial or deleterious effects on insulin sensitivity and arterial function, depending on nutritional status in our models.


Assuntos
Envelhecimento/efeitos dos fármacos , Antioxidantes/uso terapêutico , Aorta/efeitos dos fármacos , Resistência à Insulina/fisiologia , Fenóis/uso terapêutico , Ribonucleotídeo Redutases/antagonistas & inibidores , Estilbenos/uso terapêutico , Doenças Vasculares/tratamento farmacológico , Animais , Glicemia/análise , Quimiocina CCL5/sangue , Quimiocina CXCL1/sangue , Proteínas Alimentares/administração & dosagem , Modelos Animais de Doenças , Leptina/sangue , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos , Estado Nutricional , Estresse Oxidativo/efeitos dos fármacos , Resistina/análise , Resveratrol , Albumina Sérica/análise , Superóxidos/metabolismo , Fator de Necrose Tumoral alfa/análise , Capacitância Vascular/efeitos dos fármacos , Vasodilatação/efeitos dos fármacos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA